Published in Nutr Clin Pract on April 19, 2012
Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients (2013) 0.83
Metabolic remodeling in chronic heart failure. J Zhejiang Univ Sci B (2013) 0.78
Evaluation of riboflavin intakes and status of 20-64-year-old adults in South Korea. Nutrients (2014) 0.78
The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis. J Inflamm (Lond) (2014) 0.75
Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J (2009) 1.61
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J (2009) 1.57
Factors influencing underutilization of evidence-based therapies in women. Eur Heart J (2011) 1.56
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. Am J Cardiol (2010) 1.51
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study. Arch Intern Med (2012) 1.40
Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarction. Eur Heart J (2007) 1.38
Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J (2012) 1.33
Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol (2005) 1.11
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients. Arch Intern Med (2008) 1.09
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am Heart J (2009) 1.07
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients. Am J Cardiol (2010) 0.99
Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J (2006) 0.99
Missed opportunities for the secondary prevention of cardiovascular disease in Canada. Can J Cardiol (2007) 0.99
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol (2009) 0.98
Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement. J Cardiovasc Nurs (2006) 0.96
Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circ Cardiovasc Qual Outcomes (2010) 0.96
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke (2009) 0.94
Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease. Can J Cardiol (2012) 0.93
Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson (2012) 0.90
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J (2010) 0.90
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. Am Heart J (2011) 0.89
Nutritional inadequacies in patients with stable heart failure. J Am Diet Assoc (2009) 0.89
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. Am Heart J (2010) 0.88
Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J (2002) 0.87
Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2010) 0.87
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada? Eur Heart J Acute Cardiovasc Care (2013) 0.86
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. Am J Cardiol (2005) 0.86
Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. BMC Nephrol (2012) 0.84
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes. Am Heart J (2006) 0.84
The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. Atherosclerosis (2009) 0.83
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI). Diabetes Care (2010) 0.83
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada. Nephrol Dial Transplant (2011) 0.82
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J (2009) 0.81
Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes. Am Heart J (2013) 0.81
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Can J Cardiol (2011) 0.81
Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome. Am J Cardiol (2007) 0.81
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes. Am J Cardiol (2011) 0.81
Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials. Am J Cardiol (2010) 0.81
Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience. Am Heart J (2009) 0.80
Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol (2011) 0.80
Use and timing of coronary angiography and associated in-hospital outcomes in Canadian non-ST-segment elevation myocardial infarction patients: insights from the Canadian Global Registry of Acute Coronary Events. Can J Cardiol (2013) 0.80
Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Can J Cardiol (2012) 0.79
Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J (2010) 0.79
Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats. Nutr Metab Cardiovasc Dis (2008) 0.79
Correlates of left ventricular mass in chronic hemodialysis recipients. Int J Cardiovasc Imaging (2013) 0.79
QRS prolongation in patients with acute coronary syndromes. Am Heart J (2010) 0.78
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J (2008) 0.78
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. Am Heart J (2013) 0.78
Thiamin deficiency and heart failure: the current knowledge and gaps in literature. Heart Fail Rev (2015) 0.78
Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease. Am J Cardiol (2010) 0.78
Assessment of right ventricular volumes and function using cardiovascular magnetic resonance cine imaging after atrial redirection surgery for complete transposition of the great arteries. Int J Cardiovasc Imaging (2012) 0.78
Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience). Am J Cardiol (2012) 0.77
Temporal trends and referral factors for cardiac rehabilitation post-acute coronary syndrome in ontario: insights from the Canadian Global Registry of Acute Coronary Events. Can J Cardiol (2013) 0.77
Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial. Am Heart J (2012) 0.76
Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. Can J Cardiol (2011) 0.76
Preoperative carbohydrate loading in patients undergoing coronary artery bypass or spinal surgery. Anesth Analg (2013) 0.76
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J (2010) 0.75
Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant Recipients. J Lipids (2012) 0.75
Better outcome of myocardial infarction in hospitals with PCI facilities--is it because of more PCIs? Arch Intern Med (2008) 0.75
Excess dosing of antithrombotic therapy in non-ST-segment elevation acute coronary syndromes. JAMA (2006) 0.75
Reviparin in acute myocardial infarction. JAMA (2005) 0.75
Misinterpretation of electrocardiograms and cardiac catheterization laboratory activations. JAMA (2008) 0.75
Sex differences in the benefits of the guidelines applied in practice project: are they due to sex? Arch Intern Med (2006) 0.75
Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy. Cardiol Res Pract (2011) 0.75
Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction. JAMA (2007) 0.75
Pre-hospital cardiac arrest in acute coronary syndromes: insights from the global registry of acute coronary events and the canadian registry of acute coronary events. Cardiology (2013) 0.75
Persistent left superior vena cava with retrograde drainage from the left atrium into the left brachiocephalic vein. J Am Coll Cardiol (2011) 0.75
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J (2009) 0.75
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice. Am J Cardiol (2008) 0.75
Multimodality imaging for resuscitated sudden cardiac death. J Cardiovasc Med (Hagerstown) (2015) 0.75
Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes. Am Heart J (2011) 0.75
Reply. J Hypertens (2017) 0.75
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes. Am Heart J (2013) 0.75
Provision of gastroprotective medication and bleeding risk following acute coronary syndrome. J Invasive Cardiol (2013) 0.75
In-center nocturnal hemodialysis. Semin Dial (2014) 0.75
Diet order entry by registered dietitians results in a reduction in error rates and time delays compared with other health professionals. J Acad Nutr Diet (2012) 0.75
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes. Am Heart J (2008) 0.75
Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal disease. J Hypertens (2017) 0.75
Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials. J Invasive Cardiol (2016) 0.75
Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease. Int J Cardiol (2013) 0.75
Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study. Can J Cardiol (2013) 0.75
The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease. J Nephrol (2010) 0.75
Multimodality imaging in the preoperative diagnosis of lipomatous hypertrophy. Can J Cardiol (2012) 0.75
The effect of endogenous estrogen on Doppler-estimated right ventricular systolic pressure during exercise. Can J Physiol Pharmacol (2012) 0.75
Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes. Am Heart J (2008) 0.75
Reply: Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis. J Am Coll Cardiol (2017) 0.75